Filing Details
Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) filed a Form 8-K with the Securities and Exchange Commission on July 15, 2026, disclosing a material event.
8k filedNASDAQ:ALDX
Aldeyra Therapeutics, Inc. (ALDX) Reports Material Event to SEC
Filing Details Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) filed a Form 8-K with the Securities and Exchange Commission on July 15, 2026, disclosing a material event. Market Context…
Market Context
Aldeyra Therapeutics, Inc.'s stock currently trades at $1.92 with a market capitalization of $328.5M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Aldeyra Therapeutics, Inc.'s stock.
All SEC filings for Aldeyra Therapeutics, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View ALDX Stock Page
Frequently Asked Questions
Where can I read ALDX's SEC filings?
Browse all filings on our ALDX SEC filings page.
What types of SEC filings does Aldeyra Therapeutics, Inc. file?
Public companies like Aldeyra Therapeutics, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.